Chemotherapy plus surgery and heat ablation for pancreatic cancer with limited liver spread
Part of Cancer clinical trials.
This trial tests a treatment for pancreatic cancer that has spread to the liver (with no more than a few liver tumors). Patients will receive chemotherapy plus surgery and a heat-based procedure (thermal ablation) to destroy the liver tumors. The goal is to see if combining these treatments helps control the cancer better than chemotherapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older with a confirmed diagnosis of pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer).
- Have no more than 3 liver tumors, and each tumor must be 5 cm or smaller (if only one tumor) or 3 cm or smaller (if multiple tumors).
- Be in generally good health, specifically with adequate liver function and a good performance score (Karnofsky score of 80 or more).
- Not have had any prior cancer treatment like chemotherapy, radiation, or ablation for this condition.
- Be able to undergo a procedure called thermal ablation, which uses heat to destroy liver tumors, with a safe ultrasound-guided path.
- Have normal blood clotting and not be on long-term blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach that combines a special type of radiation therapy (called PRaG) with an immunotherapy drug to treat advanced pancreatic cancer that hasn't spread. The goal is to see if this combination can shrink or control the tumor and help you live longer.
This trial tests a procedure that uses sound waves to heat and destroy part of the tumor, combined with an immunotherapy drug called pembrolizumab (Keytruda) that helps your immune system fight the cancer. It is for people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body.
This study tests a new treatment combining tumor destruction with heat/cold (ablation) and an immunotherapy drug (PD-1) for people whose pancreatic cancer has spread to the liver. The goal is to help the immune system fight the cancer better.
This trial tests a treatment that uses heat from a probe inserted through an endoscope to destroy pancreatic tumors that cannot be removed with surgery. It may help shrink or control the tumor and could be an option if other treatments have not worked.
This trial tests a combination of standard chemotherapy, MRI-guided radiation, and surgery for people with locally advanced pancreatic cancer that might be removable. The goal is to see if this approach can make more tumors resectable.
This trial combines two treatments for advanced pancreatic cancer that hasn't spread: a special endoscopic procedure that uses heat to destroy cancer cells (radiofrequency ablation) and a standard chemotherapy drug combination (FOLFIRINOX). The goal is to see if this combination is safe and can help control the tumor better than chemotherapy alone.
Hear when a new Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.